Yahoo Web Search

Search results

1. www.anavex.comCNS Therapeutics | Anavex Life Sciences | New York

   www.anavex.com

   • Cached

   Welcome to Anavex Life Sciences Corp. We are working to develop novel small molecule treatments for some of the most challenging central nervous system (CNS) diseases facing society today, including Alzheimer’s, Parkinson’s, Rett syndrome, and other rare diseases.

   • Newsroom

     Anavex Life Sciences announces first entire clinical...

   • Investor Material

     Anavex Life Sciences Reports Fiscal 2024 Second Quarter...

   • About Us

     Anavex Life Sciences Corp. (Nasdaq: AVXL) is a...

     Therapeutic Candidates

     · Sigmaceptor

     · Analyst Coverage

     · Letter From The CEO

     · Legal Notice

   • Contact

     Stay connected and be sure to subscribe to our mailing list.

   • Careers

     Anavex Life Sciences Corp. (the “Company”) is an equal...

   • Investors

     Learn more about how the team at Anavex Life Sciences strive...

   • 

     Long-term Clinical Study Demonstrates Disease-Modifying Effects of ANAVEX®2-73 for Rett Syndrome
   • 

     ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48Week Phase 2 Extension Study in PDD
   • 

     ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints

2. finance.yahoo.com › quote › AVXLAnavex Life Sciences Corp. (AVXL) - Yahoo Finance

   finance.yahoo.com › quote › AVXL

   • Cached

   Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product...

3. www.anavex.com › post › anavex-life-sciencesAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ...

   www.anavex.com › post › anavex-life-sciences

   • Cached

   Jan 16, 2024 · Jan 16. Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia. Placebo-controlled Phase 2 trial cleared by the FDA – Trial to begin in Q2 2024. Trial to include Schizophrenia validated clinical outcomes PANSS and EEG/ERP biomarkers.

4. Top Stories

   • 

     Seeking Alpha

     Neutral On Anavex: Evaluating The Potential In Neurodegenerative Diseases

     2 weeks ago

   • bovnews

     Are you thinking about selling now? Anavex Life Sciences Corporation (AVXL) Stock

     Cantor Fitzgerald lowered the price target for the Anavex Life Sciences Corporation (NASDAQ:AVXL) stock from “an Overweight” to “a Neutral”. The rating was released on December 06, 2022, according to finviz.

     1 week ago

   • Business Insider

     Anavex Life Sciences Announces Expansion of Leadership Team

     NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative ...

     2 weeks ago

   View all

5. finance.yahoo.com › news › anavex-life-sciencesAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase ...

   finance.yahoo.com › news › anavex-life-sciences

   • Cached

   Mar 18, 2024 · NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...

   • Author: Anavex Life Sciences Corp.

6. finance.yahoo.com › news › anavex-life-sciencesAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ...

   finance.yahoo.com › news › anavex-life-sciences

   • Cached

   Jan 16, 2024 · Tue, Jan 16, 2024, 7:30 AM 8 min read. In this article: AVXL. Anavex Life Sciences Corp. Placebo-controlled Phase 2 trial cleared by the FDA – Trial to begin in Q2 2024. Trial to include...

7. www.globenewswire.com › news-release › 2024/05/22Anavex Life Sciences Announces Expansion of Leadership

   www.globenewswire.com › news-release › 2024/05/22

   • Cached

   May 22, 2024 · NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...

8. People also ask

   Who is ANAVEX Life Sciences Corp?

   • Welcome to Anavex Life Sciences Corp. We are working to develop novel small molecule treatments for some of the most challenging central nervous system (CNS) diseases facing society today, including Alzheimer’s, Parkinson’s, Rett syndrome, and other rare diseases.

   CNS Therapeutics | Anavex Life Sciences | New York

   www.anavex.com/

   See all results for this question

   What biomarkers does ANAVEX use?

   • In addition to the electrophysiological biomarkers, Anavex is applying novel neuroinflammatory, metabolomic, and transcriptomic biomarkers at the intersection of schizophrenia pathophysiology and ANAVEX®3-71’s novel, dual mechanism of action.

   Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical

   finance.yahoo.com/news/anavex-life-sciences-initiates-placebo-113000339.html

   See all results for this question

   What is ANAVEX ®273 (blarcamesine)?

   • Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a and recently a Phase 2b/3 clinical trial for Alzheimer's disease, a Phase 2 proof-of-concept study in Parkinson's disease dementia, and both a Phase 2 and a Phase 3 study in adult patients with Rett syndrome.

   Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3

   www.anavex.com/post/anavex-life-sciences-announces-phase-2-clinical-trial-anavex-3-71-schizophrenia

   See all results for this question

   Are there any side effects of ANAVEX?

   • Often, available treatments are limited by side effects, e.g., movement disorders, sedation, weight gain, and other metabolic side effects,” said Christopher U Missling, PhD, President and Chief Executive Officer of Anavex.

   Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3

   www.anavex.com/post/anavex-life-sciences-announces-phase-2-clinical-trial-anavex-3-71-schizophrenia

   See all results for this question